O'Dell Group’s AbbVie ABBV Stock Holding History

O'Dell Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-763	Closed	-$118K	–	91
2023 Q4	$118K	Buy	+763	New	+$111K	0.03%	126
2023 Q3	–	Sell	-192	Closed	-$25.9K	–	80
2023 Q2	$25.9K	Buy	+192	New	+$28.2K	0.01%	254
2022 Q4	–	Sell	-192	Closed	-$26K	–	76
2022 Q3	$26K	Buy	192 +100	+109%	+$14.3K	0.01%	199
2022 Q2	$14K	Hold	92	–	–	0.01%	253
2022 Q1	$15K	Hold	92	–	–	﹤0.01%	278
2021 Q4	$12K	Hold	92	–	–	﹤0.01%	280
2021 Q3	$10K	Buy	+92	New	+$10.5K	﹤0.01%	286

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

O'Dell Group's ABBV Position: Q1 2024 in Review

O'Dell Group sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 763 shares — an estimated $118K sold.

O'Dell Group first reported a position in ABBV in Q3 2021 and held it in 7 quarters. The position peaked at $118K in Q4 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

O'Dell Group reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 763 AbbVie shares in Q1 2024, an estimated $118K.
O'Dell Group first reported a position in AbbVie in Q3 2021 and held it in 7 quarters.
O'Dell Group's AbbVie position peaked at $118K in Q4 2023.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.